Country and Regional Medicines Projects
WHO Regional Director for Africa calls for greater commitment to improve access to medicines in the region
Dr Matshidiso Moeti has praised the progress of the Renewed Partnership and has called for greater commitment to ensure that Africans have access to the quality, affordable medicines they need.
The African Caribbean and Pacific Group of States Secretariat, the EU and WHO launched the Renewed Partnership in 2012 to support 15 African countries to strengthen their pharmaceutical systems.
Dr Moeti, the WHO Regional Director for Africa, stressed the critical importance of the pharmaceutical sector for sustainable development and for building effective health systems. She called upon the EU “to consider continuing the Partnership with WHO in order to sustain the progress made in beneficiary countries, but also to consider expanding the partnership to additional countries that also need help to work towards Universal Health Coverage.”
- Renewed Partnership stakeholders met from 1 to 3 July 2015 in Brazzaville.
- Réunion annuelle Partenariat Renouvelé, 1-3 Juillet 2015, Brazzaville.
WHO coordinates projects that support countries to develop, implement, and monitor national policies and practices and strengthen pharmaceutical systems. The goal: to ensure that high quality essential medicines are available, affordable and used appropriately. We help countries set and agree their medicines priorities, draw up and implement plans, and monitor and evaluate them. We encourage collaboration between countries to improve quality, selection and use, and to increase availability and affordability of medicines. We promote transparency and good governance, and advocate a coordinated, multi-stakeholder approach that involves the private sector, civil society, academic and other partners.
The Good Governance for Medicines programme aims to contribute to health systems strengthening by promoting good governance in the pharmaceutical sector. 36 countries and territories have participated in the programme since its inception in 2004.
The MeTA initiative aims to improve access to quality-assured essential medicines in low-income countries through a multi-stakeholder collaboration involving representatives of the public sector, the private sector and civil society. Participating countries include Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia.